P
ProHub
English 简体中文 繁體中文
BCG Medium Merger & Acquisition

Orwells that Ends Well

#Healthcare
ProHub Comment

This M&A case requires candidates to evaluate three acquisition targets across multiple dimensions (strategic fit, economics, and risk). The case tests quantitative analysis skills through financial modeling of synergies and overlap impacts, combined with qualitative assessment of integration complexity and market opportunity.

Estimated Time 26 minutes
Difficulty Medium
Source Duke
48 / 100

Your client is Animal Pharma, a public pharmaceutical supplier focused on oral solid medications (e.g., tablets, capsules).

Animal Pharma’s portfolio has been impacted by decreasing margins.

Animal Pharma is considering the acquisition of a rival supplier to boost profitability.

Animal Pharma’s CEO has hired you to review the attractiveness of this strategy.

Clarifying Information

  1. Objective: The executive board would like for the company’s stock to increase ASAP and is looking for a quick and sustained boost.
  2. Model: Animal Pharma does not currently manufacture any of their products and are reliant on upstream partners for molecule synthesis.
  3. Geography: Animal Pharma is focused solely on domestic sales with no current international exposure.
  4. Positioning: Animal Pharma’s stock has been performing below the S&P 500 but similarly to comparable pharmaceutical companies.
Mock Interview
Interviewer

Your client is Animal Pharma, a public pharmaceutical supplier focused on oral solid medications (e.g., tablets, capsules). Animal Pharma's portfolio has been impacted by decreasing margins. Animal Pharma is considering the acquisition of a rival supplier to boost profitability. Animal Pharma's CEO has hired you to review the attractiveness of this strategy.

You

Thanks. Before analyzing, I'd like to clarify a few key questions...

Interviewer

Good question. Let me provide some background information...

You

Based on this, I suggest analyzing from these dimensions...

AI Score
Structure Analysis Communication Business Sense Quantitative
Practicing...
Score coming soon
Practice this case with AI Mock Interview

Animal Pharma, facing margin pressures, is evaluating three potential acquisitions to improve profitability. The candidate must analyze deal economics, synergy potential, product overlap, and integration risks to recommend the most attractive target given the board’s need for a quick stock boost.

Key Insights:

  1. Deal evaluation requires balancing multiple competing factors: deal price, integration difficulty, product overlap, and synergy value
  2. Co 1 offers lower risk and faster execution despite lower synergies, while Co 3 offers higher lifetime value but substantial integration risk
  3. Product overlap creates revenue loss that must be subtracted from synergy gains to calculate true net value accretion
  4. The board’s urgency for quick returns creates tension with deals requiring more complex integration